108 related articles for article (PubMed ID: 32531741)
1. Survival impacts of different nodal characteristics and T-classification in N3 nasopharyngeal carcinoma patients.
Lin TY; Lan MY; Tsou HH; Ho CY; Twu CW; Liu YC; Lin PJ; Huang PI; Shiau CY; Lin JC
Oral Oncol; 2020 Sep; 108():104820. PubMed ID: 32531741
[TBL] [Abstract][Full Text] [Related]
2. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
4. Validation of Stage N3 of the Eighth Edition AJCC Staging System for Nasopharyngeal Carcinoma.
Pan XB; Qu S; Li L; Chen L; Liang SX; Zhu XD
Laryngoscope; 2021 Mar; 131(3):535-540. PubMed ID: 32557662
[TBL] [Abstract][Full Text] [Related]
5. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
Kang M; Long J; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2016 Mar; 7(12):15252-61. PubMed ID: 26918446
[TBL] [Abstract][Full Text] [Related]
6. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
[TBL] [Abstract][Full Text] [Related]
7. Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma?
Yue D; Xu YF; Zhang F; Lin L; Mao YP; Li WF; Chen L; Sun Y; Liu LZ; Lin AH; Li L; Ma J
Radiother Oncol; 2014 Oct; 113(1):108-14. PubMed ID: 25245557
[TBL] [Abstract][Full Text] [Related]
8. Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
Kang M; Zhou P; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
Oncotarget; 2017 Sep; 8(41):70586-70594. PubMed ID: 29050304
[TBL] [Abstract][Full Text] [Related]
9. Comparing the 7th and 8th editions of UICC/AJCC staging system for nasopharyngeal carcinoma in the IMRT era.
He T; Yan RN; Chen HY; Zeng YY; Xiang ZZ; Liu F; Shao BF; Ma JC; Wang XR; Liu L
BMC Cancer; 2021 Mar; 21(1):327. PubMed ID: 33785010
[TBL] [Abstract][Full Text] [Related]
10. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
11. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
[TBL] [Abstract][Full Text] [Related]
12. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH; Kwong DL; Leung TW; Choi CW; O'Sullivan B; Lam KO; Lai V; Khong PL; Chan SK; Ng CY; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; So TH; Luk MY; Lee AW
Int J Cancer; 2019 Apr; 144(7):1713-1722. PubMed ID: 30192385
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.
Tang LL; Chen YP; Mao YP; Wang ZX; Guo R; Chen L; Tian L; Lin AH; Li L; Sun Y; Ma J
J Natl Compr Canc Netw; 2017 Jul; 15(7):913-919. PubMed ID: 28687579
[No Abstract] [Full Text] [Related]
14. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
Chen L; Mao YP; Xie FY; Liu LZ; Sun Y; Tian L; Tang LL; Lin AH; Li L; Ma J
Radiother Oncol; 2012 Sep; 104(3):331-7. PubMed ID: 22103978
[TBL] [Abstract][Full Text] [Related]
15. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.
Ai QY; King AD; Poon DMC; Mo FKF; Hui EP; Tong M; Ahuja AT; Ma BBY; Chan ATC
Oral Oncol; 2019 Jan; 88():124-130. PubMed ID: 30616782
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
[TBL] [Abstract][Full Text] [Related]
18. IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinoma.
Zhong Q; Zhu X; Li L; Qu S; Liang Z; Zeng F; Pan X
Oncotarget; 2017 Jun; 8(24):39683-39694. PubMed ID: 28147309
[TBL] [Abstract][Full Text] [Related]
19. [Rationality of N3 classification and its sub-classification in TNM classification system for advanced gastric cancer].
Cheng Y; Huang J; Zhu Z; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):749-55. PubMed ID: 27452751
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
